ATE269303T1 - Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen - Google Patents
Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionenInfo
- Publication number
- ATE269303T1 ATE269303T1 AT00903114T AT00903114T ATE269303T1 AT E269303 T1 ATE269303 T1 AT E269303T1 AT 00903114 T AT00903114 T AT 00903114T AT 00903114 T AT00903114 T AT 00903114T AT E269303 T1 ATE269303 T1 AT E269303T1
- Authority
- AT
- Austria
- Prior art keywords
- arylpiperazinyl
- depression
- treatment
- indole derivatives
- cyclohexyl
- Prior art date
Links
- 208000020401 Depressive disease Diseases 0.000 title 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22658399A | 1999-01-07 | 1999-01-07 | |
| PCT/US2000/000223 WO2000040554A1 (en) | 1999-01-07 | 2000-01-06 | Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE269303T1 true ATE269303T1 (de) | 2004-07-15 |
Family
ID=22849500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00903114T ATE269303T1 (de) | 1999-01-07 | 2000-01-06 | Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1147083B1 (de) |
| JP (1) | JP2002534411A (de) |
| KR (1) | KR20010086163A (de) |
| CN (1) | CN1166636C (de) |
| AR (1) | AR028810A1 (de) |
| AT (1) | ATE269303T1 (de) |
| AU (1) | AU2490900A (de) |
| BR (1) | BR0007424A (de) |
| CA (1) | CA2355342A1 (de) |
| CZ (1) | CZ20012444A3 (de) |
| DE (1) | DE60011570T2 (de) |
| DK (1) | DK1147083T3 (de) |
| ES (1) | ES2219302T3 (de) |
| HU (1) | HUP0200309A3 (de) |
| IL (1) | IL143979A0 (de) |
| NO (1) | NO20013369L (de) |
| PT (1) | PT1147083E (de) |
| WO (1) | WO2000040554A1 (de) |
| ZA (1) | ZA200105190B (de) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6337326B1 (en) * | 1999-11-08 | 2002-01-08 | American Home Products Corporation | N-aryl-(homopiperazinyl)-cyclohexyl amines |
| JP2003513970A (ja) * | 1999-11-08 | 2003-04-15 | ワイス | 中枢神経系障害の治療のための［（インドール−３−イル）−シクロアルキル］−３−置換アゼチジン |
| CN1821236B (zh) * | 2001-01-16 | 2010-06-23 | 阿斯特拉曾尼卡有限公司 | 治疗性杂环化合物 |
| KR20080079341A (ko) * | 2001-01-16 | 2008-08-29 | 아스트라제네카 아베 | 치료용 헤테로시클릭 화합물 |
| JP2004531506A (ja) | 2001-03-29 | 2004-10-14 | ブリストル−マイヤーズ スクイブ カンパニー | 選択的なセロトニン再取り込みインヒビターとしてのシクロプロピルインドール誘導体 |
| ES2323451T7 (es) | 2001-07-20 | 2011-08-01 | Psychogenics Inc. | Tratamiento para el trastorno de hiperactividad con deficit de atencion. |
| SE0103649D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic quinoline compounds |
| SE0103648D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic quinolone compounds |
| GB0227240D0 (en) * | 2002-11-21 | 2002-12-31 | Glaxo Group Ltd | Compounds |
| US7276603B2 (en) | 2003-05-02 | 2007-10-02 | Wyeth | Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use |
| KR20070027584A (ko) | 2004-06-17 | 2007-03-09 | 와이어쓰 | 고나도트로핀 방출 호르몬 수용체 길항제 |
| AU2005264998A1 (en) | 2004-06-17 | 2006-01-26 | Wyeth | The present invention relates to methods of making Gonadotropin Releasing Hormone ('GnRH') (also known as Leutinizing Hormone Releasing Hormone) receptor antagonists |
| US7968538B2 (en) | 2005-01-25 | 2011-06-28 | Galenea Corp. | Substituted arylamine compounds and methods of treatment |
| US7538113B2 (en) | 2005-02-18 | 2009-05-26 | Wyeth | 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7582634B2 (en) | 2005-02-18 | 2009-09-01 | Wyeth | 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7534796B2 (en) | 2005-02-18 | 2009-05-19 | Wyeth | Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7531542B2 (en) | 2005-05-18 | 2009-05-12 | Wyeth | Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
| US7582636B2 (en) | 2005-05-26 | 2009-09-01 | Wyeth | Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor |
| TW200800959A (en) | 2005-06-10 | 2008-01-01 | Wyeth Corp | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor |
| TW200808730A (en) * | 2006-06-09 | 2008-02-16 | Wyeth Corp | Process for synthesizing piperazine-piperidine compounds |
| TW200819457A (en) | 2006-08-30 | 2008-05-01 | Actelion Pharmaceuticals Ltd | Spiro antibiotic derivatives |
| CL2007003410A1 (es) * | 2006-11-28 | 2008-04-11 | Wyeth Corp | Compuestos derivados de 5-fluoro-8-{4-[4-(6-metoxiquinolin-8-il)piperazin-1-il]piperidin-1-il}quinolina; procedimiento de preparacion; compuestos intermediarios; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de trast |
| CL2008001002A1 (es) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
| CL2008001003A1 (es) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
| DE102007028925A1 (de) * | 2007-06-22 | 2008-12-24 | Saltigo Gmbh | Verfahren zur Herstellung von 2-Phenoxyacetalen und den daraus korrespondierenden 2-Phenoxycarbaldehyden |
| PL2245028T3 (pl) | 2007-12-18 | 2012-07-31 | Actelion Pharmaceuticals Ltd | Pochodne 5-aminocyklilometyloksazolidyn-2-onu |
| KR100970606B1 (ko) * | 2008-10-08 | 2010-07-20 | 장경분 | 향초 및 이를 위한 제조방법 |
| LT3141252T (lt) | 2009-06-17 | 2018-11-12 | Vertex Pharmaceuticals Inc. | Gripo virusų replikacijos inhibitoriai |
| RU2013132681A (ru) | 2010-12-16 | 2015-01-27 | Вертекс Фармасьютикалз Инкорпорейтед | Ингибиторы репликации вирусов гриппа |
| UA118010C2 (uk) | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
| JP6618901B2 (ja) | 2013-11-13 | 2019-12-11 | バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ | インフルエンザウイルスの複製の阻害剤を調製する方法 |
| LT3068776T (lt) | 2013-11-13 | 2019-08-12 | Vertex Pharmaceuticals Incorporated | Gripo virusų replikacijos inhibitoriai |
| CN103724276A (zh) * | 2013-12-13 | 2014-04-16 | 成都丽璟科技有限公司 | 一种由硝基苯胺制备苯并咪唑类化合物的新方法 |
| CN104725363B (zh) * | 2013-12-20 | 2019-03-01 | 广东东阳光药业有限公司 | 取代的哌嗪化合物及其使用方法和用途 |
| EP3083589B1 (de) * | 2013-12-20 | 2019-12-18 | Sunshine Lake Pharma Co., Ltd. | Substituierte piperazinverbindungen und verfahren zur verwendung davon |
| EP3294735B8 (de) | 2015-05-13 | 2022-01-05 | Vertex Pharmaceuticals Incorporated | Hemmer der influenzavirenreplikation |
| EP3294717B1 (de) | 2015-05-13 | 2020-07-29 | Vertex Pharmaceuticals Inc. | Verfahren zur herstellung von inhibitoren der influenzavirenreplikation |
| US10316025B2 (en) * | 2015-06-03 | 2019-06-11 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use and use thereof |
| CN109467554B (zh) * | 2017-09-07 | 2022-05-10 | 上海医药工业研究院 | 吲哚-芳杂环哌嗪(啶)类衍生物及其在抗抑郁症中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4954502A (en) * | 1988-06-10 | 1990-09-04 | Bristol-Myers Squibb Company | 1-indolyalkyl-4-(substituted-pyridinyl)piperazines |
| US5468767A (en) * | 1994-01-06 | 1995-11-21 | Bristol-Myers Squibb Company | Antidepressant 3-(aminocycloalkenyl)-indole-5-nitrile derivatives |
| DE19512639A1 (de) * | 1995-04-05 | 1996-10-10 | Merck Patent Gmbh | Benzonitrile und -fluoride |
-
2000
- 2000-01-06 ES ES00903114T patent/ES2219302T3/es not_active Expired - Lifetime
- 2000-01-06 AT AT00903114T patent/ATE269303T1/de not_active IP Right Cessation
- 2000-01-06 IL IL14397900A patent/IL143979A0/xx unknown
- 2000-01-06 JP JP2000592263A patent/JP2002534411A/ja not_active Withdrawn
- 2000-01-06 CA CA002355342A patent/CA2355342A1/en not_active Abandoned
- 2000-01-06 BR BR0007424-1A patent/BR0007424A/pt not_active Application Discontinuation
- 2000-01-06 DE DE60011570T patent/DE60011570T2/de not_active Expired - Fee Related
- 2000-01-06 HU HU0200309A patent/HUP0200309A3/hu unknown
- 2000-01-06 CN CNB008026084A patent/CN1166636C/zh not_active Expired - Fee Related
- 2000-01-06 DK DK00903114T patent/DK1147083T3/da active
- 2000-01-06 EP EP00903114A patent/EP1147083B1/de not_active Expired - Lifetime
- 2000-01-06 AR ARP000100049A patent/AR028810A1/es not_active Application Discontinuation
- 2000-01-06 AU AU24909/00A patent/AU2490900A/en not_active Abandoned
- 2000-01-06 WO PCT/US2000/000223 patent/WO2000040554A1/en not_active Ceased
- 2000-01-06 CZ CZ20012444A patent/CZ20012444A3/cs unknown
- 2000-01-06 PT PT00903114T patent/PT1147083E/pt unknown
- 2000-01-06 KR KR1020017008567A patent/KR20010086163A/ko not_active Withdrawn
-
2001
- 2001-06-22 ZA ZA200105190A patent/ZA200105190B/en unknown
- 2001-07-06 NO NO20013369A patent/NO20013369L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1336916A (zh) | 2002-02-20 |
| JP2002534411A (ja) | 2002-10-15 |
| HUP0200309A2 (en) | 2002-06-29 |
| ZA200105190B (en) | 2002-09-23 |
| CZ20012444A3 (cs) | 2002-02-13 |
| NO20013369L (no) | 2001-09-03 |
| AU2490900A (en) | 2000-07-24 |
| EP1147083B1 (de) | 2004-06-16 |
| KR20010086163A (ko) | 2001-09-08 |
| ES2219302T3 (es) | 2004-12-01 |
| DE60011570D1 (de) | 2004-07-22 |
| CN1166636C (zh) | 2004-09-15 |
| HUP0200309A3 (en) | 2003-05-28 |
| DK1147083T3 (da) | 2004-08-16 |
| WO2000040554A1 (en) | 2000-07-13 |
| BR0007424A (pt) | 2001-10-09 |
| PT1147083E (pt) | 2004-09-30 |
| IL143979A0 (en) | 2002-04-21 |
| DE60011570T2 (de) | 2004-11-25 |
| CA2355342A1 (en) | 2000-07-13 |
| AR028810A1 (es) | 2003-05-28 |
| EP1147083A1 (de) | 2001-10-24 |
| NO20013369D0 (no) | 2001-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE269303T1 (de) | Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen | |
| DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| ATE275145T1 (de) | Chinazolinderivate zur behandlung von tumoren | |
| DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| ATE308997T1 (de) | Mittel zur behandlung von erkrankungen der speiseröhre | |
| DE60028358D1 (de) | Hmg1 antagonisten zur behandlung von entzündungen | |
| ATE305306T1 (de) | Reboxetin zur behandlung von peripheren neuropathien | |
| ATE451921T1 (de) | Phenylindole zur behandlung von hiv | |
| DE60019158D1 (de) | Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien | |
| DE69934877D1 (de) | Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| DE60030554D1 (de) | Verwendungen von et743 zur behandlung von krebs | |
| ATE295174T1 (de) | Arzneimittel zur behandlung von bluthochdruck | |
| ATE279386T1 (de) | Retinoide zur behandlung von emphysem | |
| EP1117431A4 (de) | Behandlung von acidose | |
| DE69807466D1 (de) | Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten | |
| ATE273276T1 (de) | Cyclobutendion-derivate zur behandlung von artherosclerose | |
| DE60006412D1 (de) | Oxazinochinolone zur behandlung von viralen infektionen | |
| DE60021252D1 (de) | Antikonvulsiva zur behandlung von autismus | |
| DE69828998D1 (de) | Indolderivate verwendbar zur behandlung von u.a. osteoporosis | |
| DE69937692D1 (de) | Arzneimittel zur behandlung der hemicrania | |
| DE60130691D1 (de) | Indolderivate zur Behandlung von Erkrankungen des Zentralnervensystems | |
| ATE251167T1 (de) | Oxazinocarbazole zur behandlung von cns- erkrankungen | |
| ATE218866T1 (de) | Kombinationstherapie zur behandlung von aids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1147083 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |